Corporate Tech Investors

Genome & Company

Genome & Company is a corporate entity that invests in firms that align with the company's business objectives.

Venture Investor Overview

Contact Information

Background Information

Overview

Genome & Company which is researching and developing dietary supplements, cosmeceuticals, and new drugs utilizing microbiome, pursues people's happy life. We have been studying microbes and probiotics which can be applied to obesity, diabetes, acne, atopic dermatitis, and cancer complementary therapies with the vision of becoming the Asian Flagship Company of the Human Microbiome Industry and the objective of market driven product development by 2018. We seek to identify what causes diseases, integrating the functional mechanism using a simulator of the human colon microbial ecosystem and multi-omics profiling through Next generation sequencing.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

8/12/2020

Transaction History

Our records indicate that Genome & Company invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Chief Executive Officer

Pae Ji-Soo

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Genome & Company has invested in only one tech company, according to our database records. If we are missing a portfolio company, please let us know.

Browse more corporate investors:

Genik | Genome British Columbia

Share this article

About Our Corporate Tech Investor Database

Our corporate equity investment data comes from VentureDeal.com, a leading provider of corporate tech investing transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary